Other available languages: none
Brussels, 4 October 2010
The EU contribution to the Global Fund to fight AIDS, Tuberculosis and Malaria
On Tuesday, 5 October, Andris Piebalgs, the European Commissioner for Development will participate in the Third Voluntary Replenishment Pledging Conference of the Global Fund to fight AIDS, Tuberculosis and Malaria (GFATM) in New York. The conference commences on 4 October with a general debate on resources mobilisation activities, comprehensive funding policy review and statements from participants. The pledging session of the Conference will be chaired by Ban Ki Moon, UN Secretary General, while Richard Manning, former Head of OECD Development Assistance Committee (DAC), will be the operative vice-chair.
Confronting HIV/AIDS, malaria and tuberculosis remains a major challenge for many developing countries in the effort to achieve health-related Millennium Development Goals (MDGs) by 2015. The response to HIV/AIDS and other poverty diseases such as malaria and tuberculosis is an important part of the EU development agenda as outlined in the European Consensus on Development and in the Joint Statement signed on 20 December 2005, which states that the Commission will support the Global Fund to fight AIDS, Tuberculosis and Malaria (GFATM).
The EU contributions to the Global Fund to fight AIDS, Tuberculosis and Malaria
The Commission and the EU Member States have been supporting strongly the Global Fund since its creation. See the table below for figures:
Source: The Global Fund website (http://www.theglobalfund.org/en/pledges/)
Results attributable to the EU contribution to the GFATM (2002-2009)
The percentage of the overall EU contribution to the GFATM it is around 50-55%. On the bases, the estimated results (in terms of outputs covering 144 countries) attributable to the EC and EU contribution to the GFATM are the following:
HIV/AIDS, malaria and tuberculosis severely undermine overall human and social development efforts. In 2000, the Commission redefined its role and accelerated its response to fight HIV/AIDS, malaria and tuberculosis in a coherent and comprehensive framework. Based on this framework, in 2001 the Commission adopted a Programme for Action to improve the effectiveness of existing initiatives targeting the major communicable diseases and poverty reduction, make pharmaceuticals more affordable and support research and development on global public goods to confront these diseases.
The Commission policy on HIV/AIDS, malaria and tuberculosis is further spelled out in the Commission communication adopted in October 2004 A coherent European policy framework for external action to confront HIV/AIDS, malaria and tuberculosis. In April 2005, the Commission adopted a new Programme for Action, A European programme for action to confront HIV/AIDS, malaria and tuberculosis through external action 2007-2011, which proposes a series of actions at both country and global levels. The actions at country level include capacity building, enhancing human resources capacity to mitigate brain drain, broad cooperation between stakeholders, investing in social services and surveillance, monitoring health outcomes, and strengthening local production capacity for pharmaceutical products. Proposed actions at global level cover five areas: affordable pharmaceutical products, strengthening regulatory capacity in developing countries; developing new tools and interventions, strengthening partnerships with multilateral agencies and other institutions, and maintaining a strong European voice at G8 and EU summits. A major objective of the programme is to increase efforts to scale up interventions that have shown results.